TH-302 solid forms and methods related thereto
The present invention provides a new method for making TH-302 and solid forms thereof. The compound in its solid form is an effective anti-cancer agent and may be used in various pharmaceutical compositions, and are particularly effective for the treatment of cancer. The invention also provides a method for preparing such compounds and forms and for treating cancer in a mammal comprising the step of administering a therapeutically effective amount of a solid form of TH-302 thereof.
1. A process for preparing a compound of Formula V:
comprising
reacting a compound of Formula II with a reducing agent in a base followed by adding an acid to provide a compound of Formula III:
and
reacting a compound of Formula III with a trisubstituted phosphine, an oxidizing agent and a phosphorus containing compound having the formula IV:
to provide a compound of Formula V.
2. The process of claim 1 , further comprising purifying the compound of Formula V;
the process comprising filtering the compound through a solid filtration aid with a solvent selected from the group consisting of acetonitrile, ethyl acetate, n-heptane, acetone, dimethylacetamide, dimethylformamide, 1,4-dioxane, ethylene glycol, 2-propanol, 1-propanol, tetrahydrofuran.
3. The process of claim 2 wherein the solvent is acetonitrile.
4. The process of claim 1 , further comprising purifying the compound of Formula V;
comprising recrystallizing the compound of formula V from ethyl acetate.
5. The process of claim 1 , wherein the reducing agent is sodium borohydride.
6. The process of claim 5 , wherein the base is NaOH.
7. The process of claim 1 , wherein the acid is selected from the group consisting of water, acetic acid, hydrobromic acid, hydrochloric acid, sodium hydrogen phosphate, sulfuric acid, citric acid, carbonic acid, phosphoric acid, oxalic acid, boric acid and combinations thereof.
8. The process of claim 7 , wherein the acid is acetic acid.
9. The process of claim 1 , wherein the trisubstituted phosphine is triphenyl phosphine.
10. The process of claim 1 , wherein the oxidizing agent is diisopropyl azodicarboxylate.
11. The method of claim 6 , wherein the ratio of the compound of formula II to sodium borohydride is about 1:1.1 to about 1:1.5 and the concentration of NaOH is from about 0.01 M to about 0.05 M.
12. The process of claim 2 , wherein the solid filtration aid is diatomaceous earth.
13. The process of claim 1 , wherein the compound of formula IV is prepared by reacting POBr 3 with 2-bromoethylamine, or a salt thereof in a solvent wherein the water content is not more than about 0.02% v/v.
14. The process of claim 13 , further comprising converting the compound of formula IV to a compound of Formula V.
15. The process of claim 1 , wherein the compound of Formula II is prepared by:
reacting a compound of Formula I; wherein R is a C 1-6 aliphatic, C 3-10 aryl, a 3-8 membered saturated or partially unsaturated carbocyclic ring, a 3-7 membered heterocyclic ring having 1-4 heteroatoms independently selected from nitrogen, oxygen, or sulfur, or a 5-6 membered monocyclic heteroaryl ring having 1-4 heteroatoms independently selected from nitrogen, oxygen, or sulfur, each of which is optionally substituted;
with a compound of formula MOH, wherein M is selected from the group consisting of Na and K; to form a compound of Formula II:
and
purifying the compound of Formula II by filtering the compound through a solid filtration aid; with a solvent selected from the group consisting of water, acetonitrile, ethyl acetate, n-heptane, acetone, dimethylacetamide, dimethylformamide, 1, 4-dioxane, ethylene glycol, 2-propanol, 1-propanol, tetrahydrofuran and combinations thereof.
16. The process of claim 15 , wherein R in Formula I is ethyl.
17. The process of claim 15 , wherein M in MOH is Na.
18. The process of claim 15 , wherein the solid filtration aid is diatomaceous earth.